Intra-abdominal Infections, IAIs, the most common type of disease in surgical infections, the severity of which cannot be ignored. The abdominal infections cover a range of diseases ranging from acute appendixitis to post-octomy abdominal infections, acute acute acute pancreas (infection period) and septic perimenitis, which has a high incidence of death. The treatment strategy for abdominal infections has been at the centre of the medical community ‘ s attention because of its high incidence and potential lethality. The treatment of abdominal infections has faced additional challenges in recent years with the increase in the number of multi-drug-resistant bacteria, and the “presemic post-accumulation” principle is particularly important in this context.
I. Classification and hazard of abdominal infections
Cervical infection is any infection with a caesarean internal organs (including a peritoneum) that causes significant damage and causes an infectious disease when the pathogen enters the host abdominal, postperitoneal or abdominal inner organs. In terms of sources of infection, abdominal infections can be divided into community-based access to sexual and health-related abdominal infections, and complex and non-complex abdominal infections, depending on the extent of infection. The risks of abdominal infections are high, especially severe abdominal infections, often combined with sepsis or sepsis, also known as abdominal sepsis. Such infections not only threaten the life of the patient but may also lead to long-term complications such as organ dysfunction and chronic pain. Timely and effective treatment is therefore essential for the rehabilitation of patients.
II. The challenge of multiple drug-resistant bacteria
In recent years, with the widespread use of antibiotics, multiple resistance (MDRB) has become a major challenge in the treatment of abdominal infections. These drug-resistant bacteria not only add to the complexity of treatment, but can also lead to treatment failures and patient deaths. Among them, the expression of multiple resistance strains for carbon cyanide is particularly difficult because they are resistant to many commonly used antibiotics. Traditional empirical antibiotic choice strategies are often ineffective for multiple drug-resistant infections. As a result, the medical community has begun to explore new treatment strategies, in which the principle of “precipitosis” has emerged. At the heart of this principle is the early guidance of empirical antibiotics in the selection of carbon pyroacne by rapid identification of bacterial acne-sensitive results. Such strategies can be more effective in targeting drug-resistant bacteria and in increasing treatment success rates.
Implementation of the principle of “precipitine after fungi”
The implementation of the “precipitation after fungus” principle depends on the close cooperation of advanced laboratory techniques and clinical doctors. In particular, this process includes the following steps: 1. Rapid identification of carbon cyanodease types: rapid identification of the carrying of carbon carcinolase genes in pathogens through advanced molecular biology techniques such as gene sequencing and mass spectrometry. This step can provide an important basis for the choice of subsequent antibiotics. Empirical antibiotic choice: Empirical treatment of antibiotics that are active in drug-resistant bacteria is selected on the basis of the carbon-cyanase-type results before the results are produced. This step will enable effective anti-infection treatment to begin as soon as possible and reduce the rate of disease and death among patients. 3. Drug-sensitive outcome feedback and adjustment: Once the results are available, the antibiotic treatment programme should be adapted to the results to ensure that treatment is targeted and effective.
IV. Surgery treatment for abdominal infections
In addition to antibiotics, surgical treatment for abdominal infections is equally important. The main objective of surgical treatment is to limit or eliminate the infection of the stoals and to maximize the restoration of organ anatomy and physiology, by such means as stinging, cutting or irritating. 1. Sources of infection control: Timely and effective control of sources of infection is key to the treatment of abdominal infections. In the case of non-heavy patients, the control of the source of infection should be completed within 24 hours; in the case of patients with sepsis or sepsis, intervention is required in a shorter period. 2. Influencing and creating: The creation of a smooth flow is the basic principle of surgical treatment of infectious diseases. This can be done through pedal piercings (ultrasound or CT-led), endoscopes, periline kidney glasses, abdominal lenses and abdominal surgery. The purpose of the diversion is to remove the sap and control the continuous infection. 3. Organ function support: For patients with severe conditions, there is also a need for organ function support, such as resuscitation, downgrading strategies for liquid recovery, etc., to ensure the safety of patients.
Conclusions and outlook
The “precipitosis after bacteria” principle provides new ideas and approaches for the treatment of abdominal infections. This principle is more effective in addressing the challenges of multiple drug-resistant strains and in improving treatment success rates through the rapid identification of carbon cyanide-types to guide the selection of empirical antibiotics in advance. The treatment of abdominal infections, however, remains a complex process, requiring a comprehensive consideration of the specific circumstances of the patient, the characteristics of the fungi and the advantages and disadvantages of the treatment. In the future, with the progressive development of medical technology and the accumulation of clinical experience, it is believed that we can more precisely diagnose and treat abdominal infections with better treatment and quality of life for the patients. At the same time, there is a need to increase public awareness and prevention of abdominal infections and to reduce the incidence and spread of diseases.
Abdominal cavity.
